| Date | Title | Description |
| 31.08.2026 | Clinical Laserthermia Systems AB announces completion of rights issue of units | Clinical Laserthermia Systems AB announces completion of rights issue of units
Mon, Aug 31, 2026 16:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUST... |
| 31.08.2026 | Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO | Clinical Laserthermia Systems appoints Katarina Lundqvist as permanent CFO
Mon, Aug 31, 2026 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that Katarina Lundqvist has been appoint... |
| 20.08.2026 | Clinical Laserthermia Systems AB announces outcome in rights issue of units | Clinical Laserthermia Systems AB announces outcome in rights issue of units
Thu, Aug 20, 2026 21:25 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRAL... |
| 18.08.2026 | Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units | Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units
Tue, Aug 18, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR ... |
| 13.08.2026 | Last Day of Subscription in Clinical Laserthermia Systems AB’ Rights Issue of Units is 18 August 2026 | Last Day of Subscription in Clinical Laserthermia Systems AB’ Rights Issue of Units is 18 August 2026
Thu, Aug 13, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO ... |
| 06.08.2026 | Majority of CLS Board and Key Executive Management Commit to Invest in the Company’s Rights Issue | Majority of CLS Board and Key Executive Management Commit to Invest in the Company’s Rights Issue
Thu, Aug 06, 2026 08:30 CET Report this content
Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today ann... |
| 04.08.2026 | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today | The Subscription Period in Clinical Laserthermia Systems AB’ Rights Issue of Units Begins Today
Tue, Aug 04, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UN... |
| 23.07.2026 | Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million | Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million
Thu, Jul 23, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DI... |
| 17.07.2026 | CLS Publishes Half-year Report January – June 2026 | CLS Publishes Half-year Report January – June 2026
Fri, Jul 17, 2026 23:45 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half-year report for ... |
| 29.06.2026 | Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB | Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB
Mon, Jun 29, 2026 19:20 CET Report this content
Today, June 29th, 2026 the Annual General Meeting (the “AGM”) of Clinical Laserthermia System... |
| 04.06.2026 | Clinical Laserthermia Systems publishes annual report for 2025 | Clinical Laserthermia Systems publishes annual report for 2025
Thu, Jun 04, 2026 08:30 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) today published its annual report for fiscal yea... |
| 28.05.2026 | CLS enters research agreement with the U.S. National Cancer Institute | CLS enters research agreement with the U.S. National Cancer Institute
Thu, May 28, 2026 15:00 CET Report this content
Clinical Laserthermia Systems AB (“CLS” or the “Company”) today announced that it has extended its research collaboration ... |
| 28.05.2026 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026
Thu, May 28, 2026 08:30 CET Report this content
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Annual General Me... |
| 12.05.2026 | CLS Publishes Interim Report January – March 2026 | CLS Publishes Interim Report January – March 2026
Tue, May 12, 2026 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for Jan... |
| 11.05.2026 | CLS Receives Largest Purchase Order Worth SEK 23 Million for Prism[®] Business | CLS Receives Largest Purchase Order Worth SEK 23 Million for Prism[®] Business
Mon, May 11, 2026 08:30 CET Report this content
Clinical Laserthermia Systems AB (“CLS” or the “Company”) today announced that it has received purchase orders to... |
| 28.04.2026 | CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT | CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT
Tue, Apr 28, 2026 10:45 CET Report this content
Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with... |
| 20.02.2026 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2025 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2025
Fri, Feb 20, 2026 08:45 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today pub... |
| 08.01.2026 | TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands | TRANBERG[®] Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands
Thu, Jan 08, 2026 08:30 CET Report this content
Clinical Laserthermia Systems AB (CLS) today anno... |
| 12.12.2025 | CLS initiates recruitment process for permanent Chief Financial Officer | CLS initiates recruitment process for permanent Chief Financial Officer
Fri, Dec 12, 2025 21:00 CET Report this content
Clinical Laserthermia Systems AB (publ) (“CLS”) today announces that the company has decided to transition from its curr... |
| 03.12.2025 | Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prism[®][ ]branded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery | Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prism[®][ ]branded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery
Wed, Dec 03, 2025 08:30 CET Report this content
Lund,... |
| 14.11.2025 | CLS Publishes Interim Report January – September 2025 | CLS Publishes Interim Report January – September 2025
Fri, Nov 14, 2025 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for... |
| 07.10.2025 | CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results
Tue, Oct 07, 2025 22:15 CET Report this content
Lund, Sweden, October 7th, 2025 – Clinical Laserthermia Systems AB (publ) (“CLS”) today announces p... |
| 30.09.2025 | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B
Tue, Sep 30, 2025 13:35 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, I... |
| 04.09.2025 | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[®] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT
Thu, Sep 04, 2025 17:00 CET Report this content
Lund, Swede... |
| 22.08.2025 | CLS publishes half-year report January – June 2025 | CLS publishes half-year report January – June 2025
Fri, Aug 22, 2025 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report Janu... |
| 27.06.2025 | Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A | Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A
Fri, Jun 27, 2025 16:35 CET Report this content
Today, 27 June 2025, the Annual General Meeting of Clinical Laserthermia Systems AB ("CLS... |
| 06.06.2025 | Clinical Laserthermia Systems publishes annual report for 2024 | Clinical Laserthermia Systems publishes annual report for 2024
Fri, Jun 06, 2025 21:00 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) today published its annual report for fiscal year... |
| 27.05.2025 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 2025 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 2025
Tue, May 27, 2025 11:00 CET Report this content
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Annual General Me... |
| 16.05.2025 | Clinical Laserthermia Systems AB publishes Interim report for January – March 2025 | Clinical Laserthermia Systems AB publishes Interim report for January – March 2025
Fri, May 16, 2025 08:30 CET Report this content
Summary of the interim report (relates to the Group)
Three months (01/01/2025–03/31/2025)
Net sales totaled S... |
| 28.04.2025 | Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance | Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance
Mon, Apr 28, 2025 08:30 CET Report this content
Lund, Sweden – Cli... |
| 15.04.2025 | Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis
Tue, Apr 15, 2025 08:30 CET Report this content
Clinical Laser... |
| 08.04.2025 | Proposed U.S. tariffs expected to have minimal impact on CLS business | Proposed U.S. tariffs expected to have minimal impact on CLS business
Tue, Apr 08, 2025 13:45 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) clarifies that the proposed U.S. tariffs a... |
| 27.02.2025 | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion
Thu, Feb 27, 2025 08:55 CET Report this content
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY O... |
| 21.02.2025 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2024 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2024
Fri, Feb 21, 2025 08:30 CET Report this content
Summary of the year-end report (relates to the Group)
Full year (01/01/2024–12/31/2024)
Net sales totaled SEK... |
| 07.02.2025 | CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request
Fri, Feb 07, 2025 15:50 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company&q... |
| 30.01.2025 | Pioneering Advances in Prostate Cancer Treatment and European Computing Independence | In the world of medicine and technology, breakthroughs often emerge from the most unexpected places. Two recent developments—one in prostate cancer treatment and the other in computer manufacturing—highlight the relentless pursuit of innova... |
| 30.01.2025 | Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published | Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published
Thu, Jan 30, 2025 10:00 CET Report this content
Lu... |
| 14.01.2025 | CLS Recaps 2024 and Provides Outlook for 2025-26 | CLS Recaps 2024 and Provides Outlook for 2025-26
Tue, Jan 14, 2025 08:50 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024,... |
| 09.12.2024 | The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024. | The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024.
Mon, Dec 09, 2024 15:20 CET Report this c... |
| 02.12.2024 | CLS carries out a directed issue to guarantors in connection with completed exercise of warrants | CLS carries out a directed issue to guarantors in connection with completed exercise of warrants
Mon, Dec 02, 2024 11:30 CET Report this content
The board of directors of Clinical Laserthermia Systems AB ("CLS" or the "Compan... |
| 27.11.2024 | CLS Secures Funding Through Warrant Exercise and Directed Issue | Clinical Laserthermia Systems AB (CLS) is making waves in the financial waters with its recent funding maneuvers. The company has successfully exercised warrants of series TO 7 B, securing approximately SEK 22.4 million. This move is not ju... |
| 26.11.2024 | CLS receives SEK 22.4 million through the exercise of warrants of series TO 7 B and decides on a directed issue | CLS receives SEK 22.4 million through the exercise of warrants of series TO 7 B and decides on a directed issue
Tue, Nov 26, 2024 12:50 CET Report this content
The exercise period for Clinical Laserthermia Systems AB ("CLS" or the... |
| 15.11.2024 | Navigating the Waters of Corporate Finance: A Look at Recent Rights Issues | In the world of corporate finance, rights issues are like lifebuoys tossed to a ship in stormy seas. They offer companies a chance to raise capital, but they also come with deadlines and decisions that can make or break investor confidence.... |
| 13.11.2024 | CLS receives additional guarantee commitments of approximately SEK 5.8 million for warrants of series TO 7 B | CLS receives additional guarantee commitments of approximately SEK 5.8 million for warrants of series TO 7 B
Wed, Nov 13, 2024 08:30 CET Report this content
Clinical Laserthermia Systems AB ("CLS" or the "Company") has r... |
| 11.11.2024 | The exercise period for CLS warrants of series TO 7 begins today | The exercise period for CLS warrants of series TO 7 begins today
Mon, Nov 11, 2024 09:03 CET Report this content
In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrant... |
| 10.11.2024 | CLS Moves Forward: Strategic Investments and Regulatory Milestones | Clinical Laserthermia Systems AB (CLS) is making waves in the medical technology sector. Recent developments signal a robust commitment to growth and innovation. The company is not just resting on its laurels; it’s actively positioning itse... |
| 07.11.2024 | CLS takes next step towards CE marking in neurosurgery by obtaining ISO certificate according to MDR and completion of study at Skåne University Hospital | CLS takes next step towards CE marking in neurosurgery by obtaining ISO certificate according to MDR and completion of study at Skåne University Hospital
Thu, Nov 07, 2024 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia S... |
| 06.11.2024 | New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings | New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings
Wed, Nov 06, 2024 10:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the &q... |
| 01.11.2024 | CLS: Navigating Challenges and Embracing Opportunities in Neurosurgery | Clinical Laserthermia Systems AB (CLS) is at a crossroads. The company, known for its innovative laser therapy systems, is undergoing significant changes. Recent announcements reveal a commitment to strengthen its financial position and ref... |
| 31.10.2024 | CLS publishes interim report January – September 2024 | CLS publishes interim report January – September 2024
Thu, Oct 31, 2024 08:30 CET Report this content
Summary of the interim report (relates to the Group)
First nine months (01/01/2024–09/30/2024)
Net sales totaled SEK 14,171,000 (SEK 3,817... |
| 28.10.2024 | CLS enters subscription undertakings and guarantee commitments for the redemption of warrants of series TO 7 B | CLS enters subscription undertakings and guarantee commitments for the redemption of warrants of series TO 7 B
Mon, Oct 28, 2024 08:30 CET Report this content
Clinical Laserthermia Systems AB ("CLS" or the "Company") ann... |
| 21.10.2024 | Bulletin from the Extraordinary General Meeting on 21st of October in Clinical Laserthermia Systems AB | Bulletin from the Extraordinary General Meeting on 21st of October in Clinical Laserthermia Systems AB
Mon, Oct 21, 2024 11:45 CET Report this content
Today, October 21, 2024, an Extraordinary General Meeting was held in Clinical Lasertherm... |
| 02.10.2024 | CLS reschedules the publication of the Q3 2024 interim report to an earlier date and invites to a webcast | CLS reschedules the publication of the Q3 2024 interim report to an earlier date and invites to a webcast
Wed, Oct 02, 2024 10:40 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or “the Compan... |
| 10.09.2024 | Navigating the Waters of Corporate Governance: Insights from Clinical Laserthermia Systems and Dicot Pharma | In the world of corporate governance, clarity is key. Two recent announcements from Clinical Laserthermia Systems AB and Dicot Pharma AB shed light on the intricate dance of shareholder meetings and trading activities. Both companies are na... |
| 10.09.2024 | CLS Board Reshuffle: A Strategic Move for Growth | In the world of corporate governance, change is often a harbinger of new opportunities. Clinical Laserthermia Systems AB (CLS) is poised for such a transformation. The company recently announced significant changes to its Board of Directors... |
| 09.09.2024 | CLS announces proposal for changes to the Board of Directors | CLS announces proposal for changes to the Board of Directors
Mon, Sep 09, 2024 14:00 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announced that the Chairm... |
| 09.09.2024 | Notice of Extraordinary General Meeting at Clinical Laserthermia Systems | Notice of Extraordinary General Meeting at Clinical Laserthermia Systems
Mon, Sep 09, 2024 14:10 CET Report this content
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Extraordinary General Meeti... |
| 23.08.2024 | Correction: Publication of CLS half-year report, 1 June – 30 June 2024 | Correction: Publication of CLS half-year report, 1 June – 30 June 2024
Fri, Aug 23, 2024 15:30 CET Report this content
In the half-year report that was attached to the press release that was sent out today, August 23 at 8:51 a.m., two error... |
| 23.08.2024 | CLS publishes half-year report January – June 2024 | CLS publishes half-year report January – June 2024
Fri, Aug 23, 2024 08:51 CET Report this content
Summary of the half-year report (relates to the Group)
First semester (01/01/2024–06/30/2024)
Net sales totaled SEK 8,762,000 (SEK 1,839,000)... |
| 12.07.2024 | CLS announces last day of trading with BTU and first day of trading in warrants of series TO 7 | CLS announces last day of trading with BTU and first day of trading in warrants of series TO 7
Fri, Jul 12, 2024 08:30 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN O... |
| 28.06.2024 | Communique from the Annual General Meeting on Friday June 28th in Clinical Laserthermia Systems AB | Communique from the Annual General Meeting on Friday June 28th in Clinical Laserthermia Systems AB
Fri, Jun 28, 2024 16:10 CET Report this content
Today, June 28th 2024, is the Annual General Meeting (the “AGM”) of Clinical Laserthermia Sys... |
| 28.06.2024 | CLS announces outcome of rights issue | CLS announces outcome of rights issue
Fri, Jun 28, 2024 16:50 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, H... |
| 25.06.2024 | CLS enters the Italian market for Focal Laser Ablation together with the Nationwide Italian Company Tecnogamma s.r.l. | CLS enters the Italian market for Focal Laser Ablation together with the Nationwide Italian Company Tecnogamma s.r.l.
Tue, Jun 25, 2024 08:30 CET Report this content
Lund, Sweden - Clinical Laserthermia Systems AB (publ) (CLS) today announc... |
| 24.06.2024 | Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed | Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now Completed
Mon, Jun 24, 2024 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS or the "... |
| 20.06.2024 | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue
Thu, Jun 20, 2024 14:00 CET Report this content
Clinical Laserthermia Systems AB (publ) (“CLS” or the ”Company”) has drafted a supplementary pro... |
| 20.06.2024 | CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million | CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million
Thu, Jun 20, 2024 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ("CLS" or the "... |
| 10.06.2024 | CLS publishes prospectus in connection with forthcoming rights issue | CLS publishes prospectus in connection with forthcoming rights issue
Mon, Jun 10, 2024 17:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES O... |
| 07.06.2024 | Clinical Laserthermia Systems publishes annual report for 2023 | Clinical Laserthermia Systems publishes annual report for 2023
Fri, Jun 07, 2024 21:10 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) today published its annual report for fiscal yea... |
| 05.06.2024 | CLS presents its new strategic direction in a Business Update Event on June 12 | CLS presents its new strategic direction in a Business Update Event on June 12
Wed, Jun 05, 2024 09:30 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) recently announced a new strategic focus based on t... |
| 05.06.2024 | First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024 | First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
Wed, Jun 05, 2024 15:00 CET Report this cont... |
| 04.06.2024 | CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S | CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
Tue, Jun 04, 2024 17:45 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) today announ... |
| 29.05.2024 | CLS publishes interim report January – March 2024 | CLS publishes interim report January – March 2024
Wed, May 29, 2024 12:00 CET Report this content
Summary of the interim report (relates to the Group)
Three months (01/01/2024–03/31/2024)
Net sales totaled SEK 3,140,000 (SEK 587,000).
Profi... |
| 29.05.2024 | Correction: CLS publishes interim report January – March 2024 | Correction: CLS publishes interim report January – March 2024
Wed, May 29, 2024 13:20 CET Report this content
Today, on 29 May at 12:00 CEST, CLS published a press release regarding the publication of the interim report for the first quarte... |
| 27.05.2024 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024 | Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024
Mon, May 27, 2024 16:15 CET Report this content
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Annual General Mee... |
| 24.05.2024 | BioStock: CLS revises strategy – increases focus on neurosurgery | BioStock: CLS revises strategy – increases focus on neurosurgery
Fri, May 24, 2024 09:21 CET Report this content
Clinical Laserthermia Systems revises its strategy to increase the possibility of achieving the goal of reaching a positive cas... |
| 21.05.2024 | CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings | CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
Tue, May 21, 2024 08:50 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems A... |
| 14.05.2024 | CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company | CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
Tue, May 14, 2024 10:00 CET Report this content
Lund, Sweden, May 14, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “th... |
| 30.04.2024 | CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators | CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
Tue, Apr 30, 2024 08:50 CET Report this content
Lund, Sweden, April 30, 2024 – Clinical Lasert... |
| 19.04.2024 | Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split | Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
Fri, Apr 19, 2024 08:30 CET Report this content
Lund, Sweden - Today, on April 19, 2024, the board of directors of Clinical La... |
| 12.04.2024 | BioStock: CLS makes progress in prostate cancer in Europe and the US | BioStock: CLS makes progress in prostate cancer in Europe and the US
Fri, Apr 12, 2024 09:15 CET Report this content
Clinical Laserthermia Systems has treated its first prostate cancer patients in Italy and secured additional orders and agr... |
| 12.04.2024 | Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB | Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
Fri, Apr 12, 2024 14:45 CET Report this content
Today, April 12, 2024, an Extraordinary General Meeting was held in Clinical Laserth... |
| 11.04.2024 | Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system | Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system
Thu, Apr 11, 2024 08:30 CET Report this content
Lund, Sweden April 11, 2024 – Clinical Laserthermia Sys... |
| 09.04.2024 | CLS receives second order from the National Institutes of Health Clinical Center in the US | CLS receives second order from the National Institutes of Health Clinical Center in the US
Tue, Apr 09, 2024 08:30 CET Report this content
Lund, Sweden April 9, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) today a... |
| 02.04.2024 | As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy | As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy
Tue, Apr 02, 2024 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems ... |
| 28.03.2024 | CLS signs agreement with ROSE Urology for treatment of prostate cancer patients with TRANBERG Thermal Therapy System | CLS signs agreement with ROSE Urology for treatment of prostate cancer patients with TRANBERG Thermal Therapy System
Thu, Mar 28, 2024 08:30 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the compa... |
| 22.03.2024 | CLS appoints Håkan Rosqvist as interim CFO | CLS appoints Håkan Rosqvist as interim CFO
Fri, Mar 22, 2024 08:30 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) announces today that the company has appointed Håkan Rosqvist as int... |
| 11.03.2024 | Publication in Journal of Neurosurgery Demonstrates Distinct Advantages of CLS´s Core Technology in Neurosurgical MR-guided Laser Ablation | Publication in Journal of Neurosurgery Demonstrates Distinct Advantages of CLS´s Core Technology in Neurosurgical MR-guided Laser Ablation
Mon, Mar 11, 2024 13:15 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ... |
| 11.03.2024 | Notice of Extraordinary General Meeting at Clinical Laserthermia Systems AB | Notice of Extraordinary General Meeting at Clinical Laserthermia Systems AB
Mon, Mar 11, 2024 19:00 CET Report this content
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Extraordinary General Me... |
| 23.02.2024 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2023 | Clinical Laserthermia Systems AB publishes Year-end report January – December 2023
Fri, Feb 23, 2024 08:30 CET Report this content
Summary of the interim report (relates to the Group)
Full year (01/01/2023–12/31/2023)
Net sales totaled SEK ... |
| 30.01.2024 | CLS has filed a new patent application for expanded and extended protection of the company's technology for laser-based tissue ablation until 2044. | CLS has filed a new patent application for expanded and extended protection of the company's technology for laser-based tissue ablation until 2044.
Tue, Jan 30, 2024 10:00 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems... |
| 23.01.2024 | The exercise period for warrants of series TO 6 B begins today | The exercise period for warrants of series TO 6 B begins today
Tue, Jan 23, 2024 08:50 CET Report this content
Lund, Sweden - Today is the first day of the exercise period for Clinical Laserthermia Systems AB's ("CLS" or the "... |
| 22.01.2024 | The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share | The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share
Mon, Jan 22, 2024 08:50 CET Report this content
Lund, Sweden - Clinical Laserthermia Systems AB ("CLS" or the "Company") hereby anno... |
| 17.01.2024 | Clinical Laserthermia Systems’ business update: focus on accelerating commercial roll-out and updated sales ambitions | Clinical Laserthermia Systems’ business update: focus on accelerating commercial roll-out and updated sales ambitions
Wed, Jan 17, 2024 08:30 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) will give an... |
| 17.01.2024 | CLS future-proofs its core technology for MRI-guided laser ablation in a new agreement with IGT | CLS future-proofs its core technology for MRI-guided laser ablation in a new agreement with IGT
Wed, Jan 17, 2024 11:00 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that a new agreemen... |
| 15.01.2024 | CLS receives market approval for its TRANBERG portfolio by HSA in Singapore and initiates the process of commercialization in the region | CLS receives market approval for its TRANBERG portfolio by HSA in Singapore and initiates the process of commercialization in the region
Mon, Jan 15, 2024 11:20 CET Report this content
Lund, Sweden – Clinical Laserthermia Systems AB (publ) ... |
| 09.01.2024 | Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro | Clinical Laserthermia Systems receives SEK 8.1 million order from ClearPoint Neuro
Tue, Jan 09, 2024 08:30 CET Report this content
Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) today announced it has received an order for Cl... |
| 28.12.2023 | Correction: Clinical Laserthermia Systems nomination committee appointed | Correction: Clinical Laserthermia Systems nomination committee appointed
Thu, Dec 28, 2023 13:30 CET Report this content
The press release as of December 22, 2023 regarding the appointment of Nomination Committee of Clinical Laserthermia Sy... |
| 22.12.2023 | Clinical Laserthermia Systems nomination committee appointed | Clinical Laserthermia Systems nomination committee appointed
Fri, Dec 22, 2023 19:40 CET Report this content
The Nomination Committee of Clinical Laserthermia Systems AB (the "Company" or CLS") has been appointed in accordanc... |
| 19.12.2023 | CLS appoints Kristian Waldeck as VP Medical Affairs and member of the company’s management team | CLS appoints Kristian Waldeck as VP Medical Affairs and member of the company’s management team
Tue, Dec 19, 2023 12:00 CET Report this content
Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company&quo... |
| 05.12.2023 | First patient treated with TRANBERG Thermal Therapy System in nationwide French study evaluating MRI together with biopsies to detect residual prostate cancer after focal therapy | First patient treated with TRANBERG Thermal Therapy System in nationwide French study evaluating MRI together with biopsies to detect residual prostate cancer after focal therapy
Tue, Dec 05, 2023 08:40 CET Report this content
Lund, Sweden ... |
